Skip to main content
. 2021 Sep 28;12(10):1529. doi: 10.3390/genes12101529

Figure 2.

Figure 2

World map showing locations of known LRRK2(G2019S) mutant families based on MDSGene database (http://www.mdsgene.org/; 1 May 2021). North Africa and Western Europe show high frequency of this mutation indicating that clinical trials focusing on this genetic subtype of PD may benefit from focusing on these regions.